@AndrewYNg I've read plenty a beautiful theory on why one intervention or another *might* work while in practice the results just weren't there. And then sometimes we get amazing results without really knowing why, and begin to investigate further. For exa
@nickandre @wiseoldguy @Karageorgos15 @erreyedoc @FatEmperor @IMWHorvitz @LDLSkeptic @mbabco @bigfatsurprise @DrAseemMalhotra @DaveKeto "Unexpected", but we did. "SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @Ketoship: RT @wyadvd: Anti diabetes drugs massively decrease CVD QUELLE SURPRISE! @FatEmperor https://t.co/vaQicCcV8H
RT @wyadvd: Anti diabetes drugs massively decrease CVD QUELLE SURPRISE! @FatEmperor https://t.co/vaQicCcV8H
RT @ArsenaultBenoit: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms htt…
@brianedwardsmd Here's some more root cause indicators Brian ;-) (Cholesterol is sooo last decade) https://t.co/Cz8v6cz5uy
RT @wyadvd: Anti diabetes drugs massively decrease CVD QUELLE SURPRISE! @FatEmperor https://t.co/IbnbV61rwx
RT @wyadvd: Anti diabetes drugs massively decrease CVD QUELLE SURPRISE! @FatEmperor https://t.co/IbnbV61rwx
Inhibición de Sglt2 y eventos cardiovasculares: por qué sorprende los resultados EMPA-REG y mecanismos probables https://t.co/RiGXFkNwES
RT @ArsenaultBenoit: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms htt…
Anti diabetes drugs massively decrease CVD QUELLE SURPRISE! @FatEmperor https://t.co/IbnbV61rwx
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms https://t.co/g5DH1dPChr
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @DiabetologiaJnl: SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @ethanjweiss: Review outlining possible mechanisms of CV benefit with SGLT2 inhibitors https://t.co/JozLJa6N59 https://t.co/jchJR2kUrd
SGLT2 and CVD events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/o2F3SFFaqS
RT @ethanjweiss: Review outlining possible mechanisms of CV benefit with SGLT2 inhibitors https://t.co/JozLJa6N59 https://t.co/jchJR2kUrd
Review outlining possible mechanisms of CV benefit with SGLT2 inhibitors https://t.co/JozLJa6N59 https://t.co/jchJR2kUrd
RT @ABCDiab: EMPA-REG: likely mechanisms? (@DiabetologiaJnl) https://t.co/WEp08fPsOc
What's the basis of the observed impact of Empagliflozin on cardiovascular endpoints? https://t.co/8eAhk3FAED
EMPA-REG: likely mechanisms? (@DiabetologiaJnl) https://t.co/WEp08fPsOc
While the modest reduction in the primary composite outcome of myocardial infarction, stroke or cardiovascular... https://t.co/07ZwrUPCFL
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/Y3HRzPTexd
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/jlEpnlkj0o
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? https://t.co/RpapXGXzwV
I thought you would find this article useful. Diabetologia https://t.co/kawU2Sl8SI
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
RT @DanielJDrucker: Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https:…
Reduced #cardiovascular death #T2D EMPA-REG-the experts vote for #heartfailure #diuresis https://t.co/QmdWBtLYQN https://t.co/RGI4obJPDQ